Encorium Group Inc.
400 Berwyn Park 899 Cassatt Road
Suite 115
Berwyn,
PA 19312
United States - Map
Phone: 610-989-4208
Web Site: http://www.encorium.com
| Encorium Group, Inc. designs and manages clinical trials for pharmaceutical, biotechnology, and medical device industries primarily in Europe. The companys clinical research and development services supporting Phase I through Phase IV clinical trials include data management, such as CRF review and tracking, data entry, clinical/statistical reports, and writing manuscripts for publication; and biostatistics for the use of professionals to develop and review protocols, design analysis plans, and report formats in various phases of drug development. Its services also include strategic trial planning; project management; medical writing; quality assurance and compliance, such as investigator audits, pre-submission protocol compliance audits, and GCP audits; outsourcing clinical staff; and clinical trials management comprising case report form design, investigator recruitment, patient enrollment, and study monitoring and data collection. In addition, Encoriums services include study protocol design; medical and regulatory affairs, such as regulatory strategy formulation, new drug and biologic license application document preparation and review, and quality assurance and liaison; pharmacovigilance; compliance and medical report writing; patient registries; and medical device certification. It also licenses Oracle Clinical and Datafax as its clinical trials management systems. Encorium offers clinical trial services in various therapeutic areas, such as cardiovascular, nephrology, endocrinology/metabolism, hematology, diabetes, neurology, oncology, immunology, vaccines, infectious diseases, gastroenterology, dermatology, hepatology, rheumatology, urology, ophthalmology, womens health, and respiratory medicine. It was formerly known as Covalent Group, Inc. and changed its name to Encorium Group, Inc. in October 2006 in connection with the acquisition of Remedium Oy. The company was founded in 1989 and is headquartered in Wayne, Pennsylvania. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Kai Lindevall MD, Ph.D., 56
Exec. Chairman and Pres of European & Asian Operations |
$
349.00K | N/A | Dr. David Ginsberg D.O., 61
Pres and Head of North American Operations |
$
151.00K | N/A | Mr. Philip L. Calamia CPA, 46
Chief Financial Officer and Principal Accounting Officer |
$
311.00K | N/A | Mr. Paul J. Schmitt ,
Advisor |
$
20.00K | N/A | Mrs. Alison O'Neill , 44
Sr. VP of Clinical Operations |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
